Clinical Immunogenicity Considerations for Biosimilar and Interchangeable Insulin Products
Guidance for Industry - Biosimilars
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Drugs & Pharmacology | Insulin